{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-227647","form_type":"8-K","ticker":"RGNX","cik":"0001590877","company_name":"REGENXBIO Inc.","filed_at":"2023-09-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.463628+00:00","generated_at":"2026-06-11T00:31:04.061193+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"REGENXBIO enters into $150M ATM equity offering agreement with BofA Securities","bullets":["May offer and sell common stock up to $150M aggregate price under ATM Sales Agreement with BofA Securities.","Agent will receive commission up to 3% of gross proceeds; sales made at prevailing market prices.","Company not obligated to sell any shares; agreement may terminate at any time by either party.","Offering complements existing S-3 shelf registration filed December 30, 2022.","BofA has provided and may continue providing investment banking and financial services to REGENXBIO."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-227647","json":"https://secwatch.observer/filing/0001193125-23-227647.json","markdown":"https://secwatch.observer/filing/0001193125-23-227647.md","text":"https://secwatch.observer/filing/0001193125-23-227647.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590877/000119312523227647/0001193125-23-227647-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590877/000119312523227647/d548812d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T00:31:04.061193+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}